VECT
VectivBio Holding AG
NASDAQ: VECT · HEALTHCARE · PHARMACEUTICALS
$16.85
+0.00% today
Updated 2026-04-30
Market cap
$1.06B
P/E ratio
—
P/S ratio
21.08x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$0 – $0
Volume
—
VectivBio Holding AG (VECT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $27.34M |
| Revenue growth (YoY) | — | — | — | — |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | $27.34M |
| Gross margin | — | — | — | 100.0% |
| R&D | $15.98M | $43.03M | $50.18M | $73.95M |
| SG&A | $8.23M | $14.02M | $35.81M | $33.91M |
| Operating income | $-24.32M | $-57.26M | $-86.72M | $-80.52M |
| Operating margin | — | — | — | -294.5% |
| EBITDA | $-24.15M | $-57.55M | $-86.41M | $-79.85M |
| EBITDA margin | — | — | — | -292.0% |
| EBIT | $-24.32M | $-57.26M | $-86.72M | $-80.52M |
| Interest expense | $50000.00 | $554000.00 | $36000.00 | $3.16M |
| Income tax | $50000.00 | $554000.00 | $64000.00 | $107000.00 |
| Effective tax rate | -0.2% | -0.9% | -0.1% | -0.1% |
| Net income | $-23.53M | $-60.50M | $-87.01M | $-93.73M |
| Net income growth (YoY) | — | -157.1% | -43.8% | -7.7% |
| Profit margin | — | — | — | -342.8% |